Alkermes shares promoted to “Buy” by UBS analyst
In view of the fact that Alkermes Inc. experienced a decline in stock prices over the last month, the company’s
Read morebydureon
As Expenses Plummet, Amylin Pharma Narrows 2Q Losses
Earlier on Tuesday, Amylin Pharmaceuticals Inc. announced the narrowing of its losses in the second-quarter as the decline in costs
Read more